Quick Answer
BioCardia, Inc. reported Total Assets of $3.41 million for fiscal year 2025.
BioCardia, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $3.41M | -8.4% |
| 2024 | $3.72M | +24.7% |
| 2023 | $2.99M | -69.5% |
| 2022 | $9.79M | -37.7% |
| 2021 | $15.72M | -32.9% |
| 2020 | $23.42M | +205.1% |
| 2019 | $7.68M | +19.7% |
| 2018 | $6.42M | -52.6% |
| 2017 | $13.54M | -38.7% |
| 2016 | $22.08M | +354.2% |
| 2015 | $4.86M | -65.0% |
| 2014 | $13.88M | +2.4% |
| 2013 | $13.54M | +1.8% |
| 2012 | $13.30M | -3.2% |
| 2011 | $13.73M | +152.7% |
| 2010 | $5.43M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.15M | -1.9% | +194.3% |
| June 30, 2025 | $2.09M | -27.7% | -3.6% |
| March 31, 2025 | $2.17M | -19.1% | -41.8% |
| December 31, 2024 | $3.72M | +24.7% | -40.6% |
| September 30, 2024 | $6.27M | +67.3% | +116.9% |
| June 30, 2024 | $2.89M | -54.8% | +7.9% |
| March 31, 2024 | $2.68M | -62.4% | -10.3% |
| December 31, 2023 | $2.99M | -69.5% | -20.3% |
- BioCardia, Inc. showed a decrease of -8.4% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, BioCardia, Inc.’s total assets has declined by 37.2% (from $5.43 million to $3.41 million).
- The most recent figure is from BioCardia, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: